Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05848089 · ClinicalTrials.gov registry record · NA
Real-time Intervention for Suicide Risk Reduction
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT05848089: Completed NA study, sponsored by Massachusetts General Hospital.
NCT05848089 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05848089, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The aim of this study is to determine whether learning three skills for managing negative emotions and receiving reminders via smartphone to practice these skills reduces how often and how intensely one experiences emotional distress and suicidal thoughts.
Interventions
- BEHAVIORAL Ecological momentary assessment (EMA)
- BEHAVIORAL Treatment as usual (TAU)
- BEHAVIORAL Brief skills sessions plus EMI skills practice prompts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2023-09-25 |
| Est. Completion | 2025-02-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05848089
The ClinicalTrials.gov registry entry for NCT05848089 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ecological momentary assessment (EMA) is the first listed.
NCT05848089 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05848089 about?
NCT05848089 is a clinical study titled "Real-time Intervention for Suicide Risk Reduction". The aim of this study is to determine whether learning three skills for managing negative emotions and receiving reminders via smartphone to practice these skills reduces how often and how intensely one experiences emotional distress and suicidal thoughts.
What is the current status of trial NCT05848089?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2023-09-25. Estimated completion is 2025-02-19.
What interventions are being tested in trial NCT05848089?
The interventions under investigation include: Ecological momentary assessment (EMA) (BEHAVIORAL), Treatment as usual (TAU) (BEHAVIORAL), Brief skills sessions plus EMI skills practice prompts (BEHAVIORAL).
Who is sponsoring clinical trial NCT05848089?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.